Morgan Stanley’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,900	Closed	-$39K	–	7851
2021 Q1	$39K	Buy	+3,900	New	+$39K	﹤0.01%	6470